Navigation Links
Celleration Appoints Mark T. Wagner President and Chief Executive Officer
Date:7/1/2009

EDEN PRAIRIE, Minn., July 1 /PRNewswire/ -- Celleration, Inc., developer of the patented MIST Therapy(R) System, an innovative device that uses ultrasound to heal wounds, has named Mark T. Wagner as president and chief executive officer and member of Celleration's board of directors. Mr. Wagner brings a successful track record of developing and commercializing medical devices spanning 30 years to the Celleration team.

"We are delighted by the addition of Mark to the Celleration team," said Ed Spencer, Jr., Chairman of Affinity Capital Management and Chairman of Celleration's board of directors. "Mark brings a wealth of experience and a solid history of building companies and delivering results. We are absolutely confident in Mark's ability to take Celleration to its next stage of commercialization and build value for its shareholders."

Mr. Wagner has decades of leadership experience in the medical device field. Most recently, he co-founded and is Board Chairman of Orasi Medical, a spinout from the University of Minnesota that is developing a diagnostic tool for neurological diseases. Prior to co-founding Orasi, Wagner served as CEO at multiple companies including, ProVation Medical, Survivalink and Altiva. Over the course of his career, Mr. Wagner has held positions of Vice President and General Manager of Nellcor's Global Sleep Solutions Group and executive positions with GE Medical Systems. Mr. Wagner currently serves on the board of directors of BioMedix Inc. and Vital Medix. Mr. Wagner holds a BS in Business Administration from the University of Southern California.

Kevin Nickels, the previous CEO, will continue to serve as the Chief Technology and Business Development Officer. Mr. Spencer commented, "During his seven years as CEO, Kevin made a huge contribution to the development of the business and I am delighted that we will continue to have the benefit of his vision in his new role as Chief Technology and Business Development Officer."

About Celleration, Inc.:

Celleration, Inc., a privately held medical device company, was founded in 1999 to develop and commercialize its therapeutic ultrasound platform. The patented MIST Technology delivers non-contact, low-frequency, low-intensity ultrasound to the patient's injured soft tissue in a painless fashion. The chronic diabetic foot ulcer market had been the Company's initial focus. MIST Therapy(R) has since expanded to various hard to heal, chronic wounds benefiting from higher incidence of complete healing in less time than standard of care. The end results, improving patient outcomes at a lower cost to the health care industry. In addition to the Company's prospective, randomized, double-blind, sham-controlled multi-center study in diabetic foot ulcers, which resulted in a statistically significant improvement in the rate of wound closure and time to wound closure, numerous independent clinical researchers without funding from the Company has further validated this value proposition.

    Contacts:
    Chris Geyen, Chief Financial Officer
    952-224-8700

    Richard Lewis Communications, Inc.
    212-827-0020
    Andrew Mielach, Media
    amielach@rlcinc.com
    Cecelia Heer, Investors
    cheer@rlcinc.com


'/>"/>
SOURCE Celleration, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. XLHealth Appoints New Vice President of Contracting and Provider Relations
2. Wisconsin Tobacco Tax Increase Is Positive Step for Health, but Budget Disappoints by Cutting Funding for Tobacco Prevention Programs
3. Verathon Inc. Appoints Kendall Stever as Chief Financial Officer
4. Tyco Electronics Appoints Cuong Do as Senior Vice President, Corporate Strategy & Business Development
5. Symmetry Medical Appoints Chairman and Two Directors
6. GBS/CIDP Foundation International Appoints Patricia A. Bryant as Executive Director
7. DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
8. Cinergy Health Appoints Dr. Erika Schwartz as Medical Director
9. ThermoGenesis Appoints Chief Executive Officer J. Melville (Mel) Engle to Board of Directors
10. China Nepstar Chain Drugstore Appoints Chief Operating Officer
11. Darwin Appoints Becky Cox Vice President, Business Development, Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... N.J. (PRWEB) , ... October 13, 2017 , ... The ... Holly Day Market. Featuring a collection of specialty vendors and unique items from across ... personalized and quality-focused health and wellness services offered by the VNA. The boutique ...
(Date:10/13/2017)... ... 13, 2017 , ... Talented host, actor Rob Lowe, is ... a new episode of "Success Files," which is an award-winning educational program broadcasted ... each subject in-depth with passion and integrity. , Sciatica occurs when the sciatic ...
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the ... medical article to the newly revamped Cosmetic Town journal section, featuring ... transplant procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... Sept. 25, 2017   Montrium , an ... solutions, today—from the IQPC Trial Master Files & ... NL)—announced that EastHORN Clinical Services has selected ... and TMF management. EastHORN, a leading European contract ... to increase transparency to enable greater collaboration with ...
(Date:9/22/2017)... DIEGO , Sept. 22, 2017 AVACEN ... medical device is now successfully helping those with the ... Fibromyalgia diagnosed Amanda in Essex, ... dressed and washing my hair, experiencing no sleep at ... in painful spasm… I cannot recommend [the AVACEN 100] ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
Breaking Medicine Technology: